1. Hanley JP. Warfarin reversal. J Clin Pathol. 2004;57(11):1132–9.
2. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology foundation guide to warfarin therapy. Circulation. 2003;107(12):1692–711.
3. Zareh M, Davis A, Henderson S. Reversal of Warfarin-Induced Hemorrhage in the Emergency Department. West J Emerg Med. 2011;12(4):386–92.
4. Tai C, Wu H, San C, Chua D. Management of supratherapeutic international normalized ratio without bleeding after warfarin use: An evaluation of Vitamin K administration (SUPRA-WAR-K study). Can J Hosp Pharm. 2017;70(3):207–14.
5. Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, et al. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: A randomized trial. Ann Intern Med. 2009;150(5):293–300.
6. Lin Y, Jeannie C. Emergency reversal of warfarin anticoagulation. Cmaj. 2010;182(18):2004.
7. Tsu L V., Dienes JE, Dager WE. Vitamin K Dosing to Reverse Warfarin Based on INR, Route of Administration, and Home Warfarin Dose in the Acute/Critical Care Setting. Ann Pharmacother. 2012;46(12):1617–26.
8. Lubetsky A, Shasha Y, Olchovsky D, Loebstein R, Halkin H, Ezra D. Impact of pre-treatment INR level on the effect of intravenous low dose vitamin K in patients with excessive anticoagulation. Thromb Haemost. 2003;90(1):71–6.
9. Hung A, Singh S, Tait RC. A prospective randomized study to determine the optimal dose of intravenous vitamin K in reversal of over-warfarinization. Br J Haematol. 2000;109:537–9.
10. DeZee KJ, Shimeall WT, Douglas KM, Shumway NM, O’Malley PG. Treatment of excessive anticoagulation with phytonadione (vitamin K): A meta-analysis. Arch Intern Med. 2006;166(4):391–7.
11. Polito NB, Kanouse E, Jones CMC, McCann M, Refaai MA, Acquisto NM. Effect of vitamin K administration on rate of warfarin reversal. Transfusion. 2019;59(4):1202–8.
12. Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, et al. Evidence-based management of anticoagulant therapy. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 SUPPL.):e152S-e184S.
13. Panduranga P, Al-Mukhaini M, Al-Muslahi M, Haque MA, Shehab A. Management dilemmas in patients with mechanical heart valves and warfarin-induced major bleeding. World J Cardiol. 2012;4(3):54‐59. doi:10.4330/wjc.v4.i3.54